SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001641489-23-000059
Filing Date
2023-09-25
Accepted
2023-09-25 16:20:45
Documents
2
Period of Report
2023-09-25

Document Format Files

Seq Description Document Type Size
1 DEF 14C vtv-def14cxschedule14creve.htm DEF 14C 132800
2 GRAPHIC image_0.jpg GRAPHIC 5596
  Complete submission text file 0001641489-23-000059.txt   141762
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 001-37524 | Film No.: 231276079
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences